SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1

SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1

The present application relates to compounds of formula (I′) or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson&#...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bartholomeus, Johan, Bürli, Roland, Ostenfeld, Thor, Travagli, Massimiliano, Jarvis, Rebecca, Johnstone, Shawn, Terstiege, Ina, Turcotte, Stephane
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Bartholomeus, Johan
Bürli, Roland
Ostenfeld, Thor
Travagli, Massimiliano
Jarvis, Rebecca
Johnstone, Shawn
Terstiege, Ina
Turcotte, Stephane
description The present application relates to compounds of formula (I′) or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington disease (HD) and other CAG-triplet repeat (or polyglutamine) diseases, amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease), diffuse Lewy body disease, chorea-acanthocytosis, primary lateral sclerosis, multiple sclerosis (MS), frontotemporal dementia, Friedreich's ataxia, acute head injury, and epilepsy (repression of microglia activation).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2023121578A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2023121578A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2023121578A13</originalsourceid><addsrcrecordid>eNrjZDAJ9nX08VHw9fdxdQ71cQUyXEJ9HEP8g4IV_N0UQjxcFZxCnBRc_H0dPf1AIt6ujgGGPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDI2NDI0NTcwtHQmDhVADSlJ9M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1</title><source>esp@cenet</source><creator>Bartholomeus, Johan ; Bürli, Roland ; Ostenfeld, Thor ; Travagli, Massimiliano ; Jarvis, Rebecca ; Johnstone, Shawn ; Terstiege, Ina ; Turcotte, Stephane</creator><creatorcontrib>Bartholomeus, Johan ; Bürli, Roland ; Ostenfeld, Thor ; Travagli, Massimiliano ; Jarvis, Rebecca ; Johnstone, Shawn ; Terstiege, Ina ; Turcotte, Stephane</creatorcontrib><description>The present application relates to compounds of formula (I′) or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington disease (HD) and other CAG-triplet repeat (or polyglutamine) diseases, amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease), diffuse Lewy body disease, chorea-acanthocytosis, primary lateral sclerosis, multiple sclerosis (MS), frontotemporal dementia, Friedreich's ataxia, acute head injury, and epilepsy (repression of microglia activation).</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230420&amp;DB=EPODOC&amp;CC=US&amp;NR=2023121578A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230420&amp;DB=EPODOC&amp;CC=US&amp;NR=2023121578A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bartholomeus, Johan</creatorcontrib><creatorcontrib>Bürli, Roland</creatorcontrib><creatorcontrib>Ostenfeld, Thor</creatorcontrib><creatorcontrib>Travagli, Massimiliano</creatorcontrib><creatorcontrib>Jarvis, Rebecca</creatorcontrib><creatorcontrib>Johnstone, Shawn</creatorcontrib><creatorcontrib>Terstiege, Ina</creatorcontrib><creatorcontrib>Turcotte, Stephane</creatorcontrib><title>SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1</title><description>The present application relates to compounds of formula (I′) or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington disease (HD) and other CAG-triplet repeat (or polyglutamine) diseases, amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease), diffuse Lewy body disease, chorea-acanthocytosis, primary lateral sclerosis, multiple sclerosis (MS), frontotemporal dementia, Friedreich's ataxia, acute head injury, and epilepsy (repression of microglia activation).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJ9nX08VHw9fdxdQ71cQUyXEJ9HEP8g4IV_N0UQjxcFZxCnBRc_H0dPf1AIt6ujgGGPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDI2NDI0NTcwtHQmDhVADSlJ9M</recordid><startdate>20230420</startdate><enddate>20230420</enddate><creator>Bartholomeus, Johan</creator><creator>Bürli, Roland</creator><creator>Ostenfeld, Thor</creator><creator>Travagli, Massimiliano</creator><creator>Jarvis, Rebecca</creator><creator>Johnstone, Shawn</creator><creator>Terstiege, Ina</creator><creator>Turcotte, Stephane</creator><scope>EVB</scope></search><sort><creationdate>20230420</creationdate><title>SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1</title><author>Bartholomeus, Johan ; Bürli, Roland ; Ostenfeld, Thor ; Travagli, Massimiliano ; Jarvis, Rebecca ; Johnstone, Shawn ; Terstiege, Ina ; Turcotte, Stephane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2023121578A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Bartholomeus, Johan</creatorcontrib><creatorcontrib>Bürli, Roland</creatorcontrib><creatorcontrib>Ostenfeld, Thor</creatorcontrib><creatorcontrib>Travagli, Massimiliano</creatorcontrib><creatorcontrib>Jarvis, Rebecca</creatorcontrib><creatorcontrib>Johnstone, Shawn</creatorcontrib><creatorcontrib>Terstiege, Ina</creatorcontrib><creatorcontrib>Turcotte, Stephane</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bartholomeus, Johan</au><au>Bürli, Roland</au><au>Ostenfeld, Thor</au><au>Travagli, Massimiliano</au><au>Jarvis, Rebecca</au><au>Johnstone, Shawn</au><au>Terstiege, Ina</au><au>Turcotte, Stephane</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1</title><date>2023-04-20</date><risdate>2023</risdate><abstract>The present application relates to compounds of formula (I′) or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerative disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington disease (HD) and other CAG-triplet repeat (or polyglutamine) diseases, amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease), diffuse Lewy body disease, chorea-acanthocytosis, primary lateral sclerosis, multiple sclerosis (MS), frontotemporal dementia, Friedreich's ataxia, acute head injury, and epilepsy (repression of microglia activation).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2023121578A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title SMALL MOLECULE MODULATORS OF THE BTB DOMAIN OF KEAP1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A02%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bartholomeus,%20Johan&rft.date=2023-04-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2023121578A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true